| 标题 |
Patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) preferred fixed-duration treatments with less frequent administrations in the era of novel bispecific antibodies (BsAbs) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Blood 作者:Zachary Frosch; Anthony Masaquel; David Fox; Carolina Reyes; Lourenia Cassoli; et al 出版日期:2025-12-05 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)